1. Home
  2. NYXH vs EARN Comparison

NYXH vs EARN Comparison

Compare NYXH & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$5.01

Market Cap

188.1M

Sector

Health Care

ML Signal

HOLD

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.41

Market Cap

200.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYXH
EARN
Founded
2009
2012
Country
Belgium
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
188.1M
200.3M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
NYXH
EARN
Price
$5.01
$5.41
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$12.67
$5.88
AVG Volume (30 Days)
35.2K
321.3K
Earning Date
11-13-2025
02-20-2026
Dividend Yield
N/A
18.01%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,616,215.00
$35,893,000.00
Revenue This Year
$75.27
$8.43
Revenue Next Year
$277.15
$17.27
P/E Ratio
N/A
N/A
Revenue Growth
10.96
43.30
52 Week Low
$4.35
$4.33
52 Week High
$11.87
$6.82

Technical Indicators

Market Signals
Indicator
NYXH
EARN
Relative Strength Index (RSI) 55.87 59.59
Support Level $4.45 $5.23
Resistance Level $4.86 $5.39
Average True Range (ATR) 0.23 0.10
MACD 0.05 0.01
Stochastic Oscillator 90.69 88.05

Price Performance

Historical Comparison
NYXH
EARN

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

Share on Social Networks: